Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PGES inhibitors(Prostaglandin E synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H19ClF6N4O2 |
InChIKeyQLJJIKAYPMNUEM-UHFFFAOYSA-N |
CAS Registry3038861-74-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fever | Preclinical | TR | 02 Dec 2024 | |
Inflammation | Preclinical | TR | 02 Dec 2024 | |
Inflammatory pain | Preclinical | TR | 02 Dec 2024 |